Non-compartmental estimation of pharmacokinetic parameters in serial sampling designs

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 36, Issue 5, 2009, Pages 479-494

  Wolfsegger, Martin J ^a   Jaki, Thomas ^b  

^a BAXTER INNOVATIONS GMBH   (Austria)

^b LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Asymptotic; Non compartmental; Pharmacokinetics; PK parameters; Serial sampling; Sparse sampling

Indexed keywords

AREA UNDER THE CURVE; ARTICLE; DISTRIBUTION VOLUME; DRUG ADMINISTRATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; MATHEMATICAL COMPUTING; MEAN RESIDENCE TIME; MONTE CARLO METHOD; NONCOMPARTMENTAL THEORY; NONHUMAN; PRIORITY JOURNAL; SAMPLING; STEADY STATE;

ALGORITHMS; ANIMALS; AREA UNDER CURVE; COMPUTER SIMULATION; CONFIDENCE INTERVALS; HALF-LIFE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MICE; MODELS, STATISTICAL; MONTE CARLO METHOD; NONLINEAR DYNAMICS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; RESEARCH DESIGN; SAMPLE SIZE; SAMPLING STUDIES;

EID: 70350569255     PISSN: 1567567X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10928-009-9133-9     Document Type: Article

References (26)

1. Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Marcel Dekker, New York
2. Cawello W (2003) Parameters for compartment-free pharmacokinetics. Standardisation of study design, data analysis and reporting. Shaker Verlag, Aachen
3. Davidian M, Giltinan DM (1995) Nonlinear models for repeated measurement data. Chapman and Hall/CRC, Boca Raton
4. Bonate PL (2006) Pharmacokinetic-pharmacodynamic modeling and simulation. Springer, New York
5. AJ Bailer 1988 Testing for the equality of area under the curves when using destructive measurement techniques J Pharmacokinet Biopharm 16 3 303 309 10.1007/BF01062139 10.1007/BF01062139 1:STN:280:DyaL1M7isFeltg%3D%3D 3221328 (Pubitemid 18192401)
6. DD-S Tang-Liu PJ Burke 1988 The effect of azone on ocular levobunolol absorption: calculating the area under the curve and its standard error using tissue sampling compartments Pharm Res 5 4 238 241 10.1023/A:1015997814379 10.1023/A:1015997814379 1:CAS:528:DyaL1cXhvFaks70%3D 3073384
7. JR Nedelman E Gibiansky DTW Lau 1995 Applying Bailer's method for AUC confidence intervals to sparse sampling Pharm Res 12 1 124 128 10.1023/A:1016255124336 10.1023/A:1016255124336 1:CAS:528:DyaK2MXjt12it7k%3D 7724473
8. WW Piegorsch AJ Bailer 1989 Optimal design allocations for estimating area under curves for studies employing destructive sampling J Pharmacokinet Biopharm 17 4 493 507 10.1007/BF01061459 10.1007/BF01061459 1:STN:280: DyaK3c7jtlCmtA%3D%3D 2614683
9. JR Nedelman E Gibiansky 1996 The variance of a better AUC estimator for sparse, destructive sampling in toxicokinetics J Pharm Sci 85 8 884 886 10.1021/js960083a 1:CAS:528:DyaK28XktFOqtro%3D 8863282 (Pubitemid 26269487)
10. RC Gagnon JJ Peterson 1998 Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data J Pharmacokinet Biopharm 26 1 87 102 10.1023/A:1023228925137 1:CAS:528:DyaK1cXmsVGqu7Y%3D 9773394
11. H Heinzl 1996 A note on testing areas under the curve when using destructive measurement techniques J Pharmacokinet Biopharm 24 6 651 655 10.1007/BF02353485 10.1007/BF02353485 1:STN:280:DyaK2svksFCksg%3D%3D 9300355 (Pubitemid 27406372)
12. AJ Bailer SJ Ruberg 1996 Randomization tests for assessing the equality of area under curves for studies using destructive sampling J Appl Toxicol 16 5 391 395 10.1002/(SICI)1099-1263(199609)16:5<391::AID-JAT363>3.0.CO;2-C 10.1002/(SICI)1099-1263(199609)16:5<391::AID-JAT363>3.0.CO;2-C 1:CAS:528:DyaK28XmtVWju7g%3D 8889790 (Pubitemid 26330394)
13. C Hu KHP Moore YH Kim ME Sale 2004 Statistical issues in a modeling approach to assessing bioequivalence or PK similarity with presence of sparsely sampled subjects J Pharmacokinet Pharmacodyn 31 4 321 339 10.1023/B:JOPA. 0000042739.44458.e0 10.1023/B:JOPA.0000042739.44458.e0 1:CAS:528: DC%2BD2cXnvVOms7Y%3D 15563006 (Pubitemid 39287339)
14. MJ Wolfsegger 2007 Establishing bioequivalence in serial sacrifice designs J Pharmacokinet Pharmacodyn 34 1 103 113 10.1007/s10928-006-9037-x 10.1007/s10928-006-9037-x 17053981 (Pubitemid 46122550)
15. T Jaki MJ Wolfsegger M Ploner 2009 Confidence intervals for ratios of AUCs in the case of serial sampling: a comparison of seven methods Pharm Stat 8 1 12 24 10.1002/pst.321 10.1002/pst.321 18407562
16. MJ Wolfsegger T Jaki 2005 Estimation of AUC from 0 to infinity in serial sacrifice designs J Pharmacokinet Pharmacodyn 32 5-6 757 766 10.1007/s10928-005-0044-0 10.1007/s10928-005-0044-0 16328101 (Pubitemid 41772356)
17. Källén A (2008) Computational pharmacokinetics. Chapman and Hall/CRC, Boca Raton
18. Resnick SI (1999) A probability path. Birkhäuser, New York
19. Efron B, Tibshirani RJ (1993) An introduction to the bootstrap. Chapman and Hall, London
20. R Development Core Team (2009) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0
21. Jaki T, Wolfsegger MJ (2009) PK: basic non-compartmental pharmacokinetics. R package version 1.01
22. Rominger KL, Wolf M (1982) A critical view of distribution volumes. In: Bozler G, van Rossum JM (eds) Pharmacokinetics during drug development: data analysis and evaluation techniques. Gustav Fischer Verlag, Stuttgart, pp 45-64
23. EC Fieller 1954 Some problems in interval estimation J Royal Stat Soc Ser B 16 2 175 185
24. JL Schafer 1999 Multiple imputation: a primer Stat Method Med Res 8 1 3 15 10.1177/096228029900800102 10.1191/096228099671525676 1:STN:280: DyaK1M3nslajtw%3D%3D
25. Mahmood I (2005) Interspecies pharmacokinetic scaling. Principles and application of allometric scaling. Pine House Publishers, Rockville
26. Van der Vaart AW (1998) Asymptotic statistics. Cambridge University Press, Cambridge